2023-507432-20-00招募中1 期
A First-in-Human Clinical Study with ABBV-CLS-579 alone and in combination in Patients with Advanced Tumor Cancers
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 150
- 试验地点
- 8
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Global Clinical Trials Helpdesk
Scientific
Calico Life Sciences LLC
研究点 (8)
Loading locations...
相似试验
招募中
1 期
[M20-124] First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic TumorsjRCT2080225298Calico Life Sciences LLC263
招募中
不适用
A Phase 1 First-in-Human Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or Refractory Tumors(non) small cell lunger cancer + breast cancer10027655NL-OMON55246AbbVie Deutschland GmbH & Co. KG10
已完成
1 期
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsJPRN-jRCT2080225314AbbVie G.K.27
已完成
1 期
First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic TumorsAdvanced Solid Tumors CancerNCT04417465Calico Life Sciences LLC101
招募中
不适用
[M24-742]First-in-Human Study of ABBV-969 in Metastatic Castration-Resistant Prostate CancerjRCT2051240092AbbVie.G.K.12